AVXL On Watch, STSA Reels With Pain As Migraine Study Fails, HSTO To Report Alopecia Data In Q4

Today's Daily Dose brings you news about the anticipated clinical trial catalysts of Anavex Life, Histogen, and Lyra Therapeutics; disappointing migraine trial results of Satsuma, and the upcoming regulatory catalyst of Sol-Gel.

from RTT - Biotech https://ift.tt/3hlsKiu
via IFTTT